If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.685    0.065 (1.41%)
Bid:
4.70
Ask:
4.725
Spread: 0.025 (0.532%)
Market Cap: £224.86m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Joint Venture created

15 Oct 2014 07:00

RNS Number : 2667U
Seeing Machines Limited
15 October 2014
 



Seeing Machines and Australian National University Sign Truefield Joint Venture

New entity created to commercialise ophthalmic-research IP

 

15 October 2014

 

Seeing Machines Limited (AIM: SEE), the AIM listed technology company with a focus on operator monitoring and intervention sensing technologies and services, is proud to announce the formation of a new joint venture, NuCoria Pty. Ltd., with The Australian National University (ANU) to commercialise TrueField Analyzer (TFA) Intellectual Property. Leveraging Seeing Machines' patented IP, technical expertise, and ANU's technology transfer & commercialisation successes, NuCoria will be dedicated to bringing revolutionary medical devices to market.

The TrueField Analyzer was originally developed collaboratively between ANU and Seeing Machines, and each of them has licensed their relevant existing intellectual property to NuCoria. NuCoria is a strategic arrangement that allows Seeing Machines to focus on core opportunities and competencies, including its alliances with Caterpillar Global Mining and TK Holdings (part of the Takata Group) and other rapidly emerging transport sector opportunities. ANU, following its own successful sale of Lithicon for A$76m, will take the lead in managing, staffing, and funding NuCoria. Seeing Machines will have an initial interest of 18% of NuCoria, will nominate a non-executive director and will receive royalties from any future licensing deals the new Company enters into.

NuCoria will become the primary vehicle for emerging ophthalmic-technology IP from ANU research centres. Professor Ted Maddess, TFA inventor and Director of the ARC Centre of Excellence in Vision Science, said: "We have been working with Seeing Machines to produce a rapid non-contact objective way of mapping the visual fields of both eyes at the same time. We have now published 17 studies showing that the new method has utility for the top three blinding diseases: glaucoma, macular degeneration and diabetic retinopathy, and also for some neurological disorders. The method continues to evolve and improve."

Ken Kroeger, CEO of Seeing Machines, said: "This is a fantastic outcome for all parties. Our company's DNA & legacy is closely tied with the ANU, hence I firmly believe that they are the right partners to move forward with this exciting technology. While the core focus of Seeing Machines is to save lives with our Driver Safety System (DSS) in the mining and road-transport industries, being able to work with strategic partners in exciting applications of our core-technology is part-and-parcel of how we operate."

Michael Cardew-Hall, ANU Pro-Vice Chancellor of Innovation and Advancement, said: "This is an exciting development in commercialisation of the TrueField Analyzer technology. The ANU has been committed to partnering with Seeing Machines in the development of the TrueField IP which was originally generated from research at the University. We believe that it has the potential to have significant benefits in the area of ophthalmology. The links between ANU and Seeing Machines are long standing, with it originally being a start up from the University itself. The NuCoria collaboration brings the expertise of Seeing Machines and ANU together to take this technology to market."

_______________________________________

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Ben ThompsonCorporate Finance

+44 20 7220 0500

Victoria BatesCorporate Broking

Newgate Threadneedle, Investment Communications for Seeing Machines

Robyn McConnachie

 

 

Josh Royston

Tel: +44 20 7653 9852

Mob: +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

Tel: +44 20 7653 9844

Mob: +44 7789 003 223

j.royston@newgatethreadneedle.com

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia, and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar, Takata and Eye Tracking Inc as its partners and BHP Billiton, Freeport McMoran, Teck, Toll Holdings amongst its customers.

 

About The Australian National University

The Australian National University was established in 1946 to support the development of national unity and identity, to improve Australia's understanding of itself and its neighbours, and to contribute to economic development and social cohesion. ANU is a celebrated place of intensive research, education and policy engagement - setting the standard on issues of national and international importance. Its body of students is drawn from across the nation and around the world. ANU is a global university that consistently ranks amongst the world's finest educational institutions, and is a centre of unparalleled intellectual talent and research excellence. The University's research has been involved in the creation of a number of successful spin-off companies, including Seeing Machines, Beta Therapeutics and Lithicon.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMIBTTMBIBBTI
Date   Source Headline
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.